Prevalence of vitamin K and vitamin D deficiency in patients with hepatobiliary and pancreatic disorders

Nutrition Research

Volumn 29, Issue 9, 2009, Pages 676-683

  Fisher, Leon ^a   Byrnes, Elizabeth ^b   Fisher, Alexander A ^c  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c CANBERRA HOSPITAL   (Australia)

Author keywords

ERCP; Humans; Osteocalcin; Parathyroid hormone; Vitamin D; Vitamin K

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CREATININE; GAMMA GLUTAMYLTRANSFERASE; MAGNESIUM; OSTEOCALCIN; PHOSPHORUS; PREDNISOLONE; THYROXINE; TRIACYLGLYCEROL LIPASE; URSODEOXYCHOLIC ACID; VITAMIN D; VITAMIN K GROUP;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD CLOTTING DISORDER; CARBOXYLATION; COMMON BILE DUCT STONE; DISEASE ASSOCIATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HEPATOBILIARY DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERBILIRUBINEMIA; INTERNATIONAL NORMALIZED RATIO; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PANCREAS DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; PROTHROMBIN TIME; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; BILE DUCT DISEASES; BONE AND BONES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLEDOCHOLITHIASIS; ENDOSCOPY; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERBILIRUBINEMIA; LIVER DISEASES; MALE; MIDDLE AGED; ODDS RATIO; OSTEOCALCIN; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; PARATHYROID HORMONE; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

EID: 70350094557     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.09.001     Document Type: Article

References (42)

1. Cranenburg E.C., Schurgers L.J., and Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 98 (2007) 120-125
2. Kaneki M., Hosoi T., Ouchi Y., and Orimo H. Pleiotropic actions of vitamin K: protector of bone health and beyond?. Nutrition 22 (2006) 845-852
3. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 92 (2006) 4-8
4. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
5. Nelsestuen G.L., Shah A.M., and Harvey S.B. Vitamin K-dependent proteins. Vitam Horm 58 (2000) 355-389
6. Koshihara Y., and Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 12 (1997) 431-438
7. Iwamoto J., Sato Y., Takeda T., and Matsumoto H. High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature. Nutr Res 29 (2009) 221-228
8. Vermeer C., Knapen M.H., and Schurgers L.J. Vitamin K and metabolic bone disease. J Clin Pathol 51 (1998) 424-426
9. McKeown N.M., Jacques P.F., Gundberg C.M., Peterson J.W., Tucker K.L., Kiel D.P., et al. Dietary and nondietary determinants of vitamin K biochemical measures in men and women. J Nutr 132 (2002) 1329-1334
10. Kalkwarf H.J., Khoury J.C., Bean J., and Elliot J.G. Vitamin K, bone turnover, and bone mass in girls. Am J Clin Nutr 80 (2004) 1075-1080
11. Shearer M.J. Vitamin K. Lancet 345 (1995) 229-234
12. O'Connor E., Molgaard C., Michaelsen K.F., Jakobsen J., Lamberg-Allardt C.J., and Cashman K.D. Serum percentage undercarboxylated osteocalcin, a sensitive measure of vitamin K status, and its relationship to bone health indices in Danish girls. Br J Nutr 97 (2007) 661-666
13. Collier J.D., Ninkovic M., and Compston J.E. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50 Suppl 1 (2002) i1-i9
14. Shiomi S., Nishiguchi S., Kubo S., Tamori A., Habu D., Takeda T., et al. Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver. Am J Gastroenterol 97 (2002) 978-981
15. Leslie W.D., Bernstein C.N., and Leboff M.S. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125 (2003) 941-966
16. Targher G., Bertolini L., Scala L., Cigolini M., Zenari L., Falezza G., et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17 (2007) 517-524
17. Smith D.L., Shire N.J., Watts N.B., Schmitter T., Szabo G., and Zucker S.D. Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease. J Clin Densitom 9 (2006) 105-113
18. Mager D.R., McGee P.L., Furuya K.N., and Roberts E.A. Prevalence of vitamin K deficiency in children with mild to moderate chronic liver disease. J Pediatr Gastroenterol Nutr 42 (2006) 71-76
19. Fisher L., and Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 5 (2007) 513-520
20. National Health and Medical Research Council (Australia). Australian alcohol guidelines : health risks and benefits (2001), National Health and Medical Research Council, Canberra vi, 128
21. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 182 (2005) 281-285
22. Szulc P., Chapuy M.C., Meunier P.J., and Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91 (1993) 1769-1774
23. Plehwe W.E. Vitamin D deficiency in the 21st century: an unnecessary pandemic?. Clin Endocrinol (Oxf) 59 (2003) 22-24
24. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81 (2006) 353-373
25. Binkley N.C., Krueger D.C., Kawahara T.N., Engelke J.A., Chappell R.J., and Suttie J.W. A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am J Clin Nutr 76 (2002) 1055-1060
26. Gundberg C.M., Nieman S.D., Abrams S., and Rosen H. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 83 (1998) 3258-3266
27. Tsugawa N., Shiraki M., Suhara Y., Kamao M., Tanaka K., and Okano T. Vitamin K status of healthy Japanese women: age-related vitamin K requirement for gamma-carboxylation of osteocalcin. Am J Clin Nutr 83 (2006) 380-386
28. Binkley N., Krueger D., Engelke J., and Suttie J. Vitamin K deficiency from long-term warfarin anticoagulation does not alter skeletal status in male rhesus monkeys. J Bone Miner Res 22 (2007) 695-700
29. Kuwabara A., Tanaka K., Tsugawa N., Nakase H., Tsuji H., Shide K., et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int 20 (2009) 935-942
30. Thane C.W., Wang L.Y., and Coward W.A. Plasma phylloquinone (vitamin K1) concentration and its relationship to intake in British adults aged 19-64 years. Br J Nutr 96 (2006) 1116-1124
31. Shearer M.J., McBurney A., and Barkhan P. Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam Horm 32 (1974) 513-542
32. Barkhan P., and Shearer M.J. Metabolism of vitamin K1 (phylloquinone) in man. Proc R Soc Med 70 (1977) 93-96
33. Carr B.I., Kar S., Wang M., and Wang Z. Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix. Cell Biol Int 31 (2007) 929-938
34. Diamond T., Stiel D., Mason R., Lissner D., Bikle D., Wilson S., et al. Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocrinol Metab 69 (1989) 1234-1239
35. Eastell R., Dickson E.R., Hodgson S.F., Wiesner R.H., Porayko M.K., Wahner H.W., et al. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14 (1991) 296-300
36. Menon K.V., Angulo P., Weston S., Dickson E.R., and Lindor K.D. Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol 35 (2001) 316-323
37. Ormarsdottir S., Ljunggren O., Mallmin H., Michaelsson K., and Loof L. Increased rate of bone loss at the femoral neck in patients with chronic liver disease. Eur J Gastroenterol Hepatol 14 (2002) 43-48
38. Monegal A., Navasa M., Guanabens N., Peris P., Pons F., Martinez de Osaba M.J., et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60 (1997) 148-154
39. Trautwein C., Possienke M., Schlitt H.J., Boker K.H., Horn R., Raab R., et al. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 95 (2000) 2343-2351
40. Newton J., Francis R., Prince M., James O., Bassendine M., Rawlings D., et al. Osteoporosis in primary biliary cirrhosis revisited. Gut 49 (2001) 282-287
41. Janes C.H., Dickson E.R., Okazaki R., Bonde S., McDonagh A.F., and Riggs B.L. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95 (1995) 2581-2586
42. Lee N.K., and Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 19 (2008) 161-166